Same-week visits available 737-667-5566

Clinical evidence

Advanced therapies, honestly

Some wounds stall despite good standard care. Two options are often discussed for those cases: low-frequency ultrasound and cellular or amniotic products. Here is what the evidence actually shows, including where it is still limited.

First, the foundation

For most chronic wounds, the therapies with the strongest evidence are the fundamentals: offloading for diabetic foot ulcers, compression for venous leg ulcers, pressure redistribution for pressure injuries, and regular debridement with good moisture balance. Advanced therapies are considered as an add-on when a wound has stalled despite those fundamentals being done well, not as a replacement for them or a shortcut.

Low-frequency ultrasound

Low-frequency, non-contact ultrasound (the category that includes devices marketed as MIST and UltraMIST) is used to help clean and stimulate a stalled wound bed. A systematic review of the published studies concluded that the results are promising but that the evidence base is weak, with most studies being small and of lower quality.1 A later randomized, double-blind, sham-controlled trial in neuropathic diabetic foot ulcers did find greater wound-area reduction with ultrasound than with a sham treatment.2

Strength of evidence: emerging / mixed There are some encouraging trials, but the overall body of evidence is small and uneven. Low-frequency ultrasound is reasonable to consider as an adjunct for a stalled wound, but it is not an established, first-line standard of care, and it is not a guarantee of healing.

Cellular and amniotic products

Cellular and tissue-based products, including amniotic and placental membrane allografts, are applied to chronic wounds to support healing. A systematic review of amniotic membrane allografts in diabetic foot ulcers examined eight randomized trials and found reduced healing time compared with conventional care, but the authors could not combine the studies into a single pooled estimate because they were too different from one another, and the overall study quality was only good to fair.3

Strength of evidence: moderate but mixed Several randomized trials point in a favorable direction for select chronic wounds, but the studies vary in quality and design, and results are not uniformly positive. These products are best considered case by case, for a wound that has not progressed on standard care.

How we use them

Our approach is evidence-first. We get the fundamentals right, and we consider an advanced therapy only when a specific wound has stalled and the clinical picture supports it, in coordination with the patient's physician. We explain the honest evidence and the expected out-of-pocket picture before proceeding. Medicare Part B may cover medically necessary wound care and certain adjunctive therapies when eligibility and documentation criteria are met, and coverage varies by therapy and situation.

Care is provided by our Advanced Practice Providers, nurse practitioners and physician assistants, with physician oversight.

Our UltraMIST service Evidence: diabetic foot ulcers All evidence

References

  1. Chang YJR, Perry J, Cross K. Low-Frequency Ultrasound Debridement in Chronic Wound Healing: A Systematic Review of Current Evidence. Plastic Surgery (Oakville). 2017. pmc.ncbi.nlm.nih.gov/articles/PMC5626185
  2. Rastogi A, Bhansali A, Ramachandran S. Efficacy and Safety of Low-Frequency, Noncontact Airborne Ultrasound Therapy for Neuropathic Diabetic Foot Ulcers: A Randomized, Double-Blind, Sham-Control Study. International Journal of Lower Extremity Wounds. 2019;18(1):81-88. pubmed.ncbi.nlm.nih.gov/30836809
  3. Lakmal K, Basnayake O, Hettiarachchi D. Systematic review on the rational use of amniotic membrane allografts in diabetic foot ulcer treatment. BMC Surgery. 2021. pmc.ncbi.nlm.nih.gov/articles/PMC7885244

This page summarizes published clinical evidence for educational purposes. It is not medical advice or a guarantee of any outcome, and individual results vary. Whether a specific therapy is appropriate, and whether it is covered by Medicare, depends on the clinical situation, medical necessity, and documentation.